The Institute of Medicine (IOM) recently issued a report assessing the
scientific evidence behind government recommendations that adults in the
general population reduce dietary sodium intake to less than 2,300 milligrams
per day and that certain groups of people at a greater risk of developing
cardiovascular disease (CVD) reduce their salt consumption to 1,500 mg per
day. At the request of the Centers for Disease Control and Prevention, the
IOM committee responsible for the report focused on new studies examining
sodium’s direct effect on health outcomes as opposed to previous research
that used high blood pressure as “a widely accepted biological predictor of
risk for CVD and stroke.”

Based on this new research, the IOM report concludes that while the latest
science still supports salt reduction recommendations for the general
population, there is little or no new evidence to back the 1,500 mg/day
recommendation for specific population subgroups, which include African
Americans, people ages 51 and older, and those with certain medical conditions.
In particular, the IOM committee reportedly found “no evidence for
benefit and some evidence suggesting risk of adverse health outcomes
associated with sodium intake levels in ranges approximately 1,500 to 2,300
mg/day among those with diabetes, kidney disease, or CVD.” Noting a lack of
strong evidence either confirming or refuting that “these subgroups should
be treated differently than the general U.S. population,” the report also lays
out a research agenda meant to close “a number of data and methodological
gaps” that currently “make comparisons across studies difficult.”
“These new studies support previous findings that reducing sodium from very
high intake levels to moderate levels improves health,” said IOM Committee
Chair Brian Strom in a May 14, 2013, press release. “But they also suggest that
lowering sodium intake too much may actually increase a person’s risk of
some health problems.”

Meanwhile, health and consumer groups have criticized the report for allegedly failing to take the larger picture into account. “While the American Heart Association [AHA] commends the IOM for taking on the challenging topic of sodium consumption, we disagree with key conclusions,” AHA CEO Nancy Brown was quoted as saying. “The report is missing a critical component – a comprehensive review of well established evidence which links too much sodium to high blood pressure and heart disease.” See AHA Press Release, May 14, 2013.

The Center for Science in the Public Interest (CSPI) has since described the IOM report as fatally limited “by a narrow charge to examine only studies that looked at hard endpoints like heart attacks and strokes.” To this end, CSPI echoed IOM’s call for additional large-scale studies and urged health authorities to continue relying on the “mountain of evidence that higher sodium intakes raise blood pressure, and that high blood pressure raises the risk of cardiovascular disease.” See CSPI Press Release, May 14, 2013.

About The Author

For decades, manufacturers, distributors and retailers at every link in the food chain have come to Shook, Hardy & Bacon to partner with a legal team that understands the issues they face in today's evolving food production industry. Shook attorneys work with some of the world's largest food, beverage and agribusiness companies to establish preventative measures, conduct internal audits, develop public relations strategies, and advance tort reform initiatives.

Close